Approved indications
In the United States, oral albendazole is approved mainly for: (1) treatment of active neurocysticercosis (pork tapeworm larvae in the brain) in patients 1 year and older; and (2) treatment of hydatid disease (Echinococcus granulosus cysts of the liver, lung, and peritoneum) in patients 6 years and older.

Common off‑label uses and evidence
Clinicians frequently use albendazole off‑label for other helminth infections such as ascariasis, hookworm, trichuriasis, enterobiasis (pinworm), strongyloidiasis, cutaneous larva migrans, and some tissue nematode infections; evidence comes from decades of clinical experience, randomized trials in endemic areas, and its inclusion in many international and U.S. guidelines.

Efficacy expectations
For intestinal worms, symptoms (e.g., abdominal discomfort, diarrhea, itching) often begin to improve within a few days, though full clearance may require repeat dosing and stool testing; for tissue infections such as neurocysticercosis or hydatid disease, improvement is slower and typically assessed over weeks to months with imaging and clinical follow‑up. Albendazole is generally highly effective when parasites are susceptible and therapy is combined with appropriate supportive treatments (e.g., steroids or surgery for neurocysticercosis or hydatid cysts).

Comparison with similar drugs
Compared with mebendazole and other benzimidazoles, albendazole has broader tissue penetration and is often preferred for tissue and systemic helminth infections, while single‑dose cure rates for common intestinal worms are similar or slightly better depending on the species and local resistance patterns.

Typical dosing by condition (adults and older children)
For hydatid disease, a common regimen is 400 mg by mouth twice daily (with meals) for 28‑day cycles, usually repeated with breaks as directed by a specialist. For neurocysticercosis, 400 mg twice daily (or 15 mg/kg/day divided twice daily up to a usual maximum of 800 mg/day) for 8–30 days is typical. For many intestinal worms in adults, a single 400 mg oral dose, sometimes repeated after a set interval, is commonly used. Pediatric dosing is usually weight‑based, with maximum doses similar to adults.

How to take
Albendazole is taken by mouth and is best absorbed when taken with a fatty meal; tablets can usually be swallowed whole, chewed, or crushed and mixed with a small amount of soft food if needed, especially for children or patients who have difficulty swallowing.

Special instructions
For longer treatments (e.g., hydatid disease or prolonged neurocysticercosis therapy), doctors often order regular blood tests to monitor liver function and blood cell counts; corticosteroids and anticonvulsants may be prescribed alongside albendazole for neurocysticercosis to control inflammation and seizures.

Missed dose guidance
If a dose is missed during a multi‑day course, it is usually taken as soon as remembered unless it is almost time for the next scheduled dose, in which case the missed dose is skipped and the regular schedule resumed; patients should not double doses to make up for one that was missed.

Overdose
In suspected overdose, patients should seek urgent medical care or contact poison control immediately, as management is supportive and focused on monitoring for worsening side effects such as severe nausea, vomiting, dizziness, or liver or neurologic problems.

Common side effects
Short courses for intestinal worms are usually well tolerated; common side effects include headache, nausea, abdominal pain, diarrhea, dizziness, and mild, reversible increases in liver enzymes, which are generally mild to moderate and start within days of beginning treatment.

Serious or rare adverse effects
Serious reactions can include significant liver injury (hepatitis, jaundice), bone‑marrow suppression leading to low white blood cells, anemia or low platelets, severe skin reactions (such as Stevens–Johnson syndrome), and severe allergic reactions (anaphylaxis); new or worsening neurologic symptoms can occur in neurocysticercosis because dying cysts trigger inflammation and require urgent medical attention.

Warnings and precautions
Albendazole is generally avoided in pregnancy, especially during the first trimester, unless the potential benefit clearly outweighs risks; people who could become pregnant are usually advised to use effective contraception during treatment and for a short period afterward. Use caution in breastfeeding, weighing benefits and potential risks. Patients with pre‑existing liver disease, blood disorders, or very young children receiving prolonged or high‑dose therapy may need closer monitoring or alternative options.

Safety relative to other drugs
For short, single‑dose or brief courses, albendazole has a safety profile similar to or better than many other systemic antiparasitics; longer or repeated high‑dose regimens carry more risk for liver and blood problems and therefore require regular lab monitoring.

Reporting and staying updated
Side effects can be reported to the FDA MedWatch program or through a healthcare professional or pharmacist; up‑to‑date safety information is available from the FDA, CDC, and current prescribing information for albendazole.

Drug and supplement interactions
Certain medicines, such as cimetidine, dexamethasone, and praziquantel, may increase levels of albendazole’s active metabolite, while strong liver enzyme inducers (for example, some anticonvulsants like phenytoin, carbamazepine, or phenobarbital) may reduce its levels and effectiveness. Patients should tell their clinician about all prescription and non‑prescription medicines, vitamins, and herbal products they use, as interactions may require dose adjustments or alternative therapies.

Food, alcohol, and other interactions
Taking albendazole with food—preferably a fatty meal—improves absorption and effectiveness; moderate alcohol use has no specific direct interaction but may worsen liver stress, so alcohol is generally limited or avoided during treatment, especially in longer courses.

Precautions and contraindications
Albendazole should be used cautiously or may be avoided in people with known hypersensitivity to benzimidazoles, existing liver disease, significant bone‑marrow suppression, or in pregnancy unless benefits clearly outweigh risks. Patients with neurocysticercosis need careful evaluation and co‑management (for example, with steroids and seizure medicines) because treatment can worsen swelling around brain lesions.

Monitoring needs
For short single‑dose or brief courses, routine lab monitoring is often not required in otherwise healthy patients; for prolonged or high‑dose regimens, periodic liver function tests and complete blood counts are commonly recommended, and patients should be monitored clinically for signs of liver problems, bone‑marrow suppression, or neurologic changes.

Q: How long does albendazole take to work?
A: For common intestinal worms, albendazole usually starts killing parasites within hours and many people feel better within a few days, while tissue infections like neurocysticercosis or hydatid disease may require weeks to months of treatment and follow‑up imaging.

Q: Should I take albendazole with food?
A: Yes, albendazole is better absorbed and more effective when taken with food—ideally a fatty meal—unless your doctor gives you different instructions.

Q: Is albendazole safe in pregnancy or while breastfeeding?
A: Albendazole is generally avoided in pregnancy, especially in the first trimester, unless the infection is severe and no safer options exist; if you are pregnant, planning pregnancy, or breastfeeding, you should discuss risks and benefits with your healthcare provider before taking it.

Q: Do I need blood tests while taking albendazole?
A: Short single‑dose treatments for intestinal worms often do not require lab tests, but longer or high‑dose courses typically involve periodic liver function tests and blood counts to check for rare liver or bone‑marrow problems.

Q: Can albendazole be used again if I get reinfected?
A: In many cases albendazole can be used again for reinfection, but dosing and timing should be confirmed with a healthcare professional, who may also recommend treating close contacts and improving hygiene to prevent repeated infections.

Storage
Store albendazole tablets at room temperature (generally 20–25°C / 68–77°F), away from excess heat, moisture, and direct light, and keep the bottle tightly closed and out of reach of children and pets.

Disposal
Do not flush albendazole down the toilet or pour it into drains; instead, use a community drug take‑back program when available or follow local guidance for household trash (mix tablets with an unappealing substance, place in a sealed container, then discard).